[HTML][HTML] The role of microtubules in the immune system and as potential targets for gut-based immunotherapy

T Ilan-Ber, Y Ilan - Molecular immunology, 2019 - Elsevier
Microtubules (MTs) are tubular polymers of tubulin that are highly dynamic and found
throughout the cytoplasm. MTs are involved in maintaining cell structure and, together with …

[HTML][HTML] Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with …

…, E Berkov, D Diker, A Zaidman, A Nutman, T Ilan Ber… - Plos one, 2021 - journals.plos.org
Background Treatment of severely ill COVID-19 patients requires simultaneous management
of oxygenation and inflammation without compromising viral clearance. While multiple …

[HTML][HTML] A host signature based on TRAIL, IP-10, and CRP for reducing antibiotic overuse in children by differentiating bacterial from viral infections: a prospective …

…, L Etshtein, N Mastboim, E Moscoviz, TI Ber… - Clinical Microbiology …, 2022 - Elsevier
Objectives Identifying infection aetiology is essential for appropriate antibiotic use. Previous
studies have shown that a host-protein signature consisting of TNF-related apoptosis-…

[HTML][HTML] Host test based on tumor necrosis factor-related apoptosis-inducing ligand, interferon gamma-induced protein-10 and C-reactive protein for differentiating …

…, TM Gottlieb, E Barash, R Navon, T Ilan-Ber… - Clinical Microbiology …, 2023 - Elsevier
Objectives To assess the performance of a test (called BV), integrating the blood levels of
three immune proteins into a score, to differentiate bacterial from viral infection among adults …

[HTML][HTML] An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease

NS Mastboim, A Angel, O Shaham, TI Ber, R Navon… - Cytokine, 2023 - Elsevier
COVID-19 patients are oftentimes over- or under-treated due to a deficit in predictive
management tools. This study reports derivation of an algorithm that integrates the host levels of …

Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status

…, AY Cohen, S Shalata, AA Hamed, T Ilan Ber… - Cancers, 2024 - mdpi.com
Simple Summary This study focused on immune checkpoint inhibitor therapy effectiveness
in patients with non-small cell lung cancer (NSCLC), particularly concerning programmed …

An immune-protein signature combining TRAIL, IP-10 and CRP for accurate prediction of severe COVID-19 outcome

NS Mastboim, A Angel, O Shaham, TI Ber, R Navon… - medRxiv, 2021 - medrxiv.org
BACKGROUND Accurately identifying COVID-19 patients at-risk to deteriorate remains
challenging. Tools integrating host-protein expression have proven useful in determining …

Biomarkers for Nonalcoholic Steatohepatitis

TI Ber, Y Ilan - Gastroenterology, 2018 - gastrojournal.org
We congratulate the authors on a very well-done and in-depth presentation of the potential
biomarkers for nonalcoholic steatohepatitis. We support their conclusion that the presented …

32. Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome

A Angel, NS Mastboim, O Shaham, TI Ber… - Open forum …, 2021 - academic.oup.com
Background Accurately identifying COVID-19 patients at-risk to deteriorate remains challenging.
Dysregulated immune responses impact disease progression and development of life-…

Real-time IP-10 measurements as a new tool for inflammation regulation within a clinical decision support protocol for managing severe COVID-19 patients

…, E Berkov, D Diker, A Zaidman, A Nutman, TI Ber… - medRxiv, 2020 - medrxiv.org
The challenge of treating severely ill COVID-19 patients is particularly great due to the need
to simultaneously manage oxygenation and the inflammatory state without compromising …